Mostafa Izanlu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mostafa Izanlu has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Ahmad Saadat
Department of Surgery Mashhad University of Medical Sciences Mashhad Iran mums.ac.ir
1 shared publication- Amir Raoofi
Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran
1 shared publication Atefeh Sahebkari
Department of Radiation Oncology Torbat Jam University of Medical Sciences Torbat-e-Jam Iran
1 shared publication- Davood Nasiry
Department of Paramedicine, Amol School of Paramedical Sciences, Mazandaran University of Medical Sciences, Sari, Iran
1 shared publication Ehsan Hassanzadeh Haddad
Surgical Oncology Research Center Mashhad University of Medical Sciences Mashhad Iran mums.ac.ir
1 shared publication- Elnaz Vafadar Moradi
Department of Emergency Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Surgery
- Vol. 2026 (1)
Male Secretory Breast Carcinoma: Two Rare Case Reports and Literature Review
Background: Secretory breast carcinoma (SBC) is an uncommon type of breast cancer, accounting for less than 0.15% of all cases. Its occurrence in males is extremely uncommon and may result in diagnostic delay due to nonspecific clinical, radiologic, and histopathologic features. Methods: In this study, two cases of SBC with distinct clinical presentations are reported, including a 15‐year‐old adolescent and a 26‐year‐old man. Clinical findings, imaging characteristics, histopathologic features, immunohistochemical (IHC) profiles, treatment strategies, and outcomes were reviewed and analyzed in the context of the current literature. Results: Both patients presented with slowly growing breast masses and a triple‐negative profile that were diagnosed based on histopathology and IHC findings. In the adolescent case, sentinel lymph node biopsy revealed limited nodal metastasis, and the patient was treated with mastectomy followed by adjuvant chemotherapy and planned radiotherapy, with no evidence of recurrence at 6 months. Initially, the adult patient was misdiagnosed, which delayed the accurate diagnosis. Moreover, a rapid local progression occurred after initial excision due to the misdiagnosis. However, the patient showed a good clinical response after neoadjuvant chemotherapy, modified radical mastectomy(MRM), and radiotherapy. These cases highlighted the biological and clinical heterogeneity of SBC despite its generally favorable prognosis. Conclusion: SBC in males remains a diagnostic challenge due to its rarity and overlapping features with other benign and malignant breast lesions. The diagnosis of SBC requires high clinical suspicion, along with detailed histopathologic, immunophenotypic, and molecular evaluation. Individualized and multidisciplinary management and long‐term follow‐up are essential to optimize outcomes in this rare entity.
- 1 January 2026
- Published by Wiley in Case Reports in Surgery
- Vol. 2026 (1)
Open AccessMale Secretory Breast Carcinoma: Two Rare Case Reports and Literature Review
Background: Secretory breast carcinoma (SBC) is an uncommon type of breast cancer, accounting for less than 0.15% of all cases. Its occurrence in males is extremely uncommon and may result in diagnostic delay due to nonspecific clinical, radiologic, and histopathologic features. Methods: In this study, two cases of SBC with distinct clinical presentations are reported, including a 15‐year‐old adolescent and a 26‐year‐old man. Clinical findings, imaging characteristics, histopathologic features, immunohistochemical (IHC) profiles, treatment strategies, and outcomes were reviewed and analyzed in the context of the current literature. Results: Both patients presented with slowly growing breast masses and a triple‐negative profile that were diagnosed based on histopathology and IHC findings. In the adolescent case, sentinel lymph node biopsy revealed limited nodal metastasis, and the patient was treated with mastectomy followed by adjuvant chemotherapy and planned radiotherapy, with no evidence of recurrence at 6 months. Initially, the adult patient was misdiagnosed, which delayed the accurate diagnosis. Moreover, a rapid local progression occurred after initial excision due to the misdiagnosis. However, the patient showed a good clinical response after neoadjuvant chemotherapy, modified radical mastectomy(MRM), and radiotherapy. These cases highlighted the biological and clinical heterogeneity of SBC despite its generally favorable prognosis. Conclusion: SBC in males remains a diagnostic challenge due to its rarity and overlapping features with other benign and malignant breast lesions. The diagnosis of SBC requires high clinical suspicion, along with detailed histopathologic, immunophenotypic, and molecular evaluation. Individualized and multidisciplinary management and long‐term follow‐up are essential to optimize outcomes in this rare entity.
- 25 September 2022
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (12) , 6939-6950
Decellularized human amniotic membrane engraftment in combination with adipose‐derived stem cells transplantation, synergistically improved diabetic wound healing
Background: One of the most important and common complications of diabetes is a disorder and defect in diabetic wound healing.Aims: The aim of present study was to investigate the synergistic effects of decellularized human amniotic membrane (dHAM) engraftment and adipose‐derived stem cells (ADSs) transplantation in the healing of delayed and ischemic diabetic wound.Methods: Sixty diabetic male rats were randomly divided into four groups (n = 15), including untreated (Control) group, engraftment by dHAM (dHAM) group, transplanted by ADSs (ADS) group, and engraftment by dHAM plus transplanted by ADSs (dHAM + ADS) group. Sampling was performed on Days 7, 14, and 21 after surgery. Evaluation tests included stereology, immunohistochemistry, molecular, and biomechanical.Results: Our results showed that the wound closure rate, volumes of newly formed epidermis and dermis, density of fibroblasts and blood vessels, collagen deposition, density of proliferation cells, expression levels of TGF‐β and VEGF genes, and biomechanical characteristics were significantly higher in all treated groups compared with control group; however, these changes were considerable in the combination group. This is while that the density of neutrophils and expression levels of TNF‐α and IL‐1β genes in the treated groups, especially in the combination group, were significantly reduced compared with control group.Conclusion: Generally, the simultaneous use of dHAM and ADS accelerates healing and improves the quality of repaired diabetic wounds.
- 25 September 2022
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (12) , 6939-6950
Decellularized human amniotic membrane engraftment in combination with adipose‐derived stem cells transplantation, synergistically improved diabetic wound healing
Background: One of the most important and common complications of diabetes is a disorder and defect in diabetic wound healing.Aims: The aim of present study was to investigate the synergistic effects of decellularized human amniotic membrane (dHAM) engraftment and adipose‐derived stem cells (ADSs) transplantation in the healing of delayed and ischemic diabetic wound.Methods: Sixty diabetic male rats were randomly divided into four groups (n = 15), including untreated (Control) group, engraftment by dHAM (dHAM) group, transplanted by ADSs (ADS) group, and engraftment by dHAM plus transplanted by ADSs (dHAM + ADS) group. Sampling was performed on Days 7, 14, and 21 after surgery. Evaluation tests included stereology, immunohistochemistry, molecular, and biomechanical.Results: Our results showed that the wound closure rate, volumes of newly formed epidermis and dermis, density of fibroblasts and blood vessels, collagen deposition, density of proliferation cells, expression levels of TGF‐β and VEGF genes, and biomechanical characteristics were significantly higher in all treated groups compared with control group; however, these changes were considerable in the combination group. This is while that the density of neutrophils and expression levels of TNF‐α and IL‐1β genes in the treated groups, especially in the combination group, were significantly reduced compared with control group.Conclusion: Generally, the simultaneous use of dHAM and ADS accelerates healing and improves the quality of repaired diabetic wounds.